Eli Lilly's GLP-1 Sales Surge Boosts Financial Outlook | Retatrutide News

Eli Lilly's financial outlook has improved due to strong sales of GLP-1 agonists. The Medicare Bridge program contributed to this success by enhancing p...
Market News · October 30, 2026